Filter
159
Text search:
Bedaquiline
Featured
28
51
Language
Document type
109
17
16
8
5
2
1
1
Countries / Regions
16
14
12
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
35
32
2
2
1
Toolboxes
115
5
4
4
3
2
2
1
1
Interim policy guidance
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
A survey of prevention, testing and treatment policies and practices
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of
...
